MustGrow Biologics Corp.
MGRO.V · TSXV
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CA$789 | CA$2,849 | CA$3,782 | CA$119 |
| % Growth | -72.3% | -24.7% | 3,082.3% | – |
| Cost of Goods Sold | CA$622 | CA$2,255 | CA$3,241 | CA$94 |
| Gross Profit | CA$167 | CA$595 | CA$541 | CA$25 |
| % Margin | 21.2% | 20.9% | 14.3% | 21.3% |
| R&D Expenses | CA$155 | CA$81 | CA$122 | CA$251 |
| G&A Expenses | CA$1,659 | CA$512 | CA$840 | CA$665 |
| SG&A Expenses | CA$2,203 | CA$1,194 | CA$1,580 | CA$785 |
| Sales & Mktg Exp. | CA$544 | CA$683 | CA$740 | CA$120 |
| Other Operating Expenses | CA$232 | CA$292 | CA$314 | CA$232 |
| Operating Expenses | CA$2,589 | CA$1,568 | CA$2,017 | CA$1,268 |
| Operating Income | -CA$2,422 | -CA$973 | -CA$1,475 | -CA$1,243 |
| % Margin | -306.9% | -34.2% | -39% | -1,045.6% |
| Other Income/Exp. Net | -CA$8 | -CA$116 | -CA$165 | CA$30 |
| Pre-Tax Income | -CA$2,430 | -CA$1,089 | -CA$1,640 | -CA$1,213 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | -CA$2,430 | -CA$1,089 | -CA$1,640 | -CA$1,213 |
| % Margin | -307.9% | -38.2% | -43.4% | -1,020.8% |
| EPS | -0.044 | -0.021 | -0.032 | -0.024 |
| % Growth | -112.4% | 34.3% | -35.3% | – |
| EPS Diluted | -0.044 | -0.021 | -0.032 | -0.024 |
| Weighted Avg Shares Out | 54,707 | 52,128 | 51,641 | 51,641 |
| Weighted Avg Shares Out Dil | 54,707 | 52,128 | 51,641 | 51,641 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$3 | CA$4 | CA$14 | CA$25 |
| Interest Expense | CA$9 | CA$53 | CA$185 | CA$0 |
| Depreciation & Amortization | CA$13 | CA$13 | CA$11 | -CA$30 |
| EBITDA | -CA$2,407 | -CA$1,023 | -CA$1,587 | -CA$1,243 |
| % Margin | -305% | -35.9% | -42% | -1,045.6% |